During the past decade, Wilkes-Barre General Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wilkes-Barre General Hospital" #1 sponsor was "Radiation Therapy Oncology Group" with 36 trials, followed by "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored, "SWOG Cancer Research Network" with 1 trials sponsored and "Vertos Medical, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wilkes-Barre General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 38 trials as a collaborator, "Eastern Cooperative Oncology Group" with 3 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator and "Radiation Therapy Oncology Group" with 3 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Wilkes-Barre General Hospital" are "Head and Neck Cancer" (8 trials), "Prostate Cancer" (7 trials), "Lung Cancer" (5 trials), "Metastatic Cancer" (5 trials) and "Brain and Central Nervous System Tumors" (4 trials). Many other conditions were trialed in "Wilkes-Barre General Hospital" in a lesser frequency.

Most popular intervention types in "Wilkes-Barre General Hospital" are "Radiation" (32 trials), "Drug" (26 trials), "Procedure" (15 trials), "Biological" (7 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (28 trials), "conventional surgery" (9 trials), "cisplatin" (6 trials), "paclitaxel" (6 trials) and "filgrastim" (5 trials). Other intervention names were less common.

The vast majority of trials in "Wilkes-Barre General Hospital" are 32 trials for "All" genders, 6 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Wilkes-Barre General Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Wilkes-Barre General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wilkes-Barre General Hospital, 8 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".